The "Intermediate" CD14 + CD16 + monocyte Subpopulation Plays a Role in IVIG Responsiveness of Children with Kawasaki Disease

Overview

Journal Pediatr Rheumatol Online J

Publisher Biomed Central

Specialty Pediatrics

Date 2021 Jun 1

PMID 34059085

Citations 4

Authors

Yi Seul Kim

Hyun Jin Yang

Seung-Jung Kee

Insu Choi

Kisoo Ha

Katrina K Ki

In Seok Jeong

Hwa Jin Cho

Affiliations

Soon will be listed here.

Abstract

Background: Kawasaki disease (KD) is an acute, self-limited febrile illness of unknown cause. Intravenous immunoglobulin (IVIG)-resistance are related to greater risk for permanent cardiac complications. We aimed to determine the correlation between monocytes and the phenotype of KD in relation to IVIG responsiveness in children.

Materials And Methods: The study cohort included 62 patients who were diagnosed with KD, 20 non febrile healthy controls (NFC), and 15 other febrile controls (OFC). In all enrolled patients, blood was taken at least 4 times and laboratory tests were performed. In addition, subtypes of monocytes were characterized via flow cytometry.

Results: The numbers of intermediate monocytes were significantly lower in IVIG-resistant group compared to IVIG-responsive group before IVIG infusion (p < 0.0001). After infusion, intermediate monocytes decreased in the responsive group, while a trend of increase was observed in the resistant group. Only intermediate monocytes were significant in logistic regression with adjusted OR of 0.001 and p value of 0.03.

Conclusions: CD14 + CD16 + intermediate monocyte may play an important role in IVIG responsiveness among KD children. Low starting levels of intermediate monocytes, followed by a dramatic increase post-IVIG infusion during acute phase of KD are associated with IVIG-resistance. Functional studies on intermediate monocyte may help to reveal the pathophysiology.

Citing Articles

Platelet-Monocyte Aggregate Instigates Inflammation and Vasculopathy in Kawasaki Disease.

Zhang Y, Jia C, Guo M, Chen Q, Wen Y, Wang T Adv Sci (Weinh). 2024; 12(5):e2406282.

PMID: 39665236 PMC: 11792051. DOI: 10.1002/advs.202406282.

Long-term cardiovascular inflammation and fibrosis in a murine model of vasculitis induced by cell wall extract.

Lombardi Pereira A, Aubuchon E, Moreira D, Lane M, Carvalho T, Mesquita T Front Immunol. 2024; 15:1411979.

PMID: 38989288 PMC: 11234797. DOI: 10.3389/fimmu.2024.1411979.

Single-Cell Analysis Reveals the Role of the Neuropeptide Receptor FPR2 in Monocytes in Kawasaki Disease: A Bioinformatic Study.

Wang T, Liu G, Guo X, Ji W Dis Markers. 2022; 2022:1666240.

PMID: 35692878 PMC: 9177323. DOI: 10.1155/2022/1666240.

Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease.

Choi I, Lee M, Choi S, Choi K, Jeong I, Cho H Front Pediatr. 2022; 9:792870.

PMID: 35186822 PMC: 8855096. DOI: 10.3389/fped.2021.792870.

Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease.

Liu J, Yang X, Pan J, Wei Z, Liu P, Chen M Front Neurol. 2022; 12:807646.

PMID: 35095746 PMC: 8795627. DOI: 10.3389/fneur.2021.807646.

References

Seite J, Hillion S, Harbonnier T, Pers J . Review: intravenous immunoglobulin and B cells: when the product regulates the producer. Arthritis Rheumatol. 2014; 67(3):595-603. DOI: 10.1002/art.38910. View

Koga M, Ishihara T, Takahashi M, Umezawa Y, Furukawa S . Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation. Pathol Int. 1998; 48(7):512-7. DOI: 10.1111/j.1440-1827.1998.tb03942.x. View

Son M, Gauvreau K, Ma L, Baker A, Sundel R, Fulton D . Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 2009; 124(1):1-8. DOI: 10.1542/peds.2008-0730. View

Pua H, Dzhagalov I, Chuck M, Mizushima N, He Y . A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med. 2006; 204(1):25-31. PMC: 2118420. DOI: 10.1084/jem.20061303. View

Katayama K, Matsubara T, Fujiwara M, Koga M, Furukawa S . CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol. 2000; 121(3):566-70. PMC: 1905728. DOI: 10.1046/j.1365-2249.2000.01321.x. View

Yeung R . Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol. 2010; 22(5):551-60. DOI: 10.1097/BOR.0b013e32833cf051. View

McCrindle B, Rowley A, Newburger J, Burns J, Bolger A, Gewitz M . Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017; 135(17):e927-e999. DOI: 10.1161/CIR.0000000000000484. View

Ichiyama T, Yoshitomi T, Nishikawa M, Fujiwara M, Matsubara T, Hayashi T . NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol. 2001; 99(3):373-7. DOI: 10.1006/clim.2001.5026. View

Sugawara T, Hattori S, Hirose S, Furukawa S, YABUTA K, Shirai T . Immunopathology of the skin lesion of Kawasaki disease. Prog Clin Biol Res. 1987; 250:185-92. View

10.

Wong K, Tai J, Wong W, Han H, Sem X, Yeap W . Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011; 118(5):e16-31. DOI: 10.1182/blood-2010-12-326355. View

11.

Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, YABUTA K . Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr. 1992; 151(1):44-7. DOI: 10.1007/BF02073890. View

12.

Furukawa S, Matsubara T, YABUTA K . Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child. 1992; 67(6):706-8. PMC: 1793803. DOI: 10.1136/adc.67.6.706. View

13.

Swirski F, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P . Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009; 325(5940):612-6. PMC: 2803111. DOI: 10.1126/science.1175202. View

14.

Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M . Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol. 2005; 174(9):5837-45. DOI: 10.4049/jimmunol.174.9.5837. View

15.

Grip O, Bredberg A, Lindgren S, Henriksson G . Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease. Inflamm Bowel Dis. 2007; 13(5):566-72. DOI: 10.1002/ibd.20025. View

16.

Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K . Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2006; 166(2):131-7. DOI: 10.1007/s00431-006-0223-z. View

17.

Terai M, Kohno Y, Namba M, Umemiya T, Niwa K, Nakajima H . Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol. 1990; 21(2):231-4. DOI: 10.1016/0046-8177(90)90135-r. View

18.

Shi C, Pamer E . Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011; 11(11):762-74. PMC: 3947780. DOI: 10.1038/nri3070. View

19.

Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T . Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006; 113(22):2606-12. DOI: 10.1161/CIRCULATIONAHA.105.592865. View

20.

Maury C, Salo E, Pelkonen P . Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med. 1989; 113(5):651-4. View